Skip to main content
. 2021 Sep 11;59(6):804–809. doi: 10.1016/j.resinv.2021.08.001

Table 1.

Characteristics of patients with COVID-19 and comparisons between the critical and non-critical groups.

Characteristics Total number of patients (n = 300) Critical group (n = 86) Non-critical group (n = 214) p-valuea
Age, y 60 (41–74) 69 (60–78) 51 (35–67) <0.001
Age ≥65 y, n (%) 118 (39.3) 53 (61.6) 65 (30.4) <0.001
Male sex, n (%) 187 (62.3) 63 (73.3) 124 (57.9) 0.017
Body mass index, kg/m2 22.9 (20.3–26.4) 23.1 (20.9–27.1) 23.0 (20.3–26.0) 0.20
Body mass index of ≥25 kg/m2, n (%) 106 (35.3) 35 (40.7) 71 (33.2) 0.23
Time from onset to visiting our center, d 6 (4–9) 8 (5–11) 6 (3–9) 0.004
Never smoked, n (%) 176 (58.7) 46 (53.5) 130 (60.7) 0.30
Former smoker, n (%) 94 (31.3) 33 (38.4) 61 (28.5) 0.10
Current smoker, n (%) 30 (10.0) 7 (8.1) 23 (10.7) 0.67
Brinkman index of ≥600, n (%) 52 (17.3) 21 (24.4) 31 (14.5) 0.044
Comorbidities, n 1 (0–2) 1 (0–2) 0 (0–1) <0.001
Hypertension, n (%) 95 (31.7) 41 (47.7) 54 (25.2) <0.001
Diabetes, n (%) 76 (25.3) 37 (43.0) 39 (18.2) <0.001
Cancerb, n (%) 29 (9.7) 8 (9.3) 21 (9.8) 1.0
Hemodialysis, n (%) 21 (7.0) 14 (16.3) 7 (3.3) <0.001
Chronic heart diseases, n (%) 36 (12.0) 15 (17.4) 21 (9.8) 0.078
COPD, n (%) 7 (2.3) 3 (3.5) 4 (1.9) 0.41
ILD, n (%) 5 (1.7) 2 (2.3) 3 (1.4) 0.63
Clinical findings
 Need for O2 supplementation upon diagnosis, n (%) 48 (16.0) 36 (41.9) 12 (5.6) <0.001
 CRP level, mg/dL 3.60 (0.72–8.63) 8.33 (5.18–14.9) 1.86 (0.36–5.90) <0.001
 CRP level of ≥6.5 mg/dL, n (%) 101 (33.7) 53 (61.6) 48 (22.4) <0.001
Outcome
 Death, n (%) 25 (8.3) 25 (29.1) 0 (0.0) <0.001

Data were presented as number of patients (%) or median (interquartile ranges).

COVID-19: coronavirus disease 2019, COPD: chronic obstructive pulmonary disease, ILD: interstitial lung disease, CRP: C-reactive protein.

a

Fisher's exact test was used to assess categorical variables and the Mann-Whitney U test, to compare continuous variables between the critical and non-critical groups.

b

Cancer types included genitourinary (11 cases), gastrointestinal (7 cases), breast (7 cases), lung (4 cases), gynecologic (2 cases), and head and neck (2 cases) cancers. Four patients had histories of two cancers.